Akoya Biosciences Inc (AKYA) saw an uptrend of 0.74% in the recent trading with $1.36 being its most recent. The current price level -60.23% lower than the highest price of $3.42 marked by the stock while trading over the past 52-weeks, whereas it is 46.08% higher than the lowest price of $0.93 the company dropped to over past 52-weeks. The latest news story on AKYA appeared in (PR Newswire) under the title “Kent Lake Responds to Quanterix’s Post-Effective Amendment and Akoya’s Superior $1.40-per-Share Alternative Proposal” on May-23-25.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Hold by 5 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.
Akoya Biosciences Inc Earnings – What Happened With AKYA
Coming around sales and income figures on AKYA Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Akoya Biosciences Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 49.84 million. AKYA does have institutional investors; and they hold 24.53% of the stock.
As on 2024-06-30, BLUE WATER LIFE SCIENCE ADVISORS, LP was the top most holder in Akoya Biosciences Inc (NASDAQ:AKYA) with an ownership of 4.7 million shares of the company or 9.5058 of the stake worth $10.99 million. The filing also reveals BLACKROCK INC. as the second largest holder in the company with a control over 3.039 of the outstanding shares. Its stake is worth $3.51 million for having 1.5 million shares in hand.
VANGUARD GROUP INC also came holding a key position in the company during the recent quarter and it now holds 2.9621 of the outstanding shares. With this there are now 95.0 institutions which have possession in AKYA’s shares.
Key Metrics forAKYA
Technical Analysis of Akoya Biosciences Inc (NASDAQ:AKYA) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Akoya Biosciences Inc (AKYA), we notice that the stock’s 20-day average volume is at 464,490 shares. Medium term indicators at an average of 50% are spotting the stock at Sell with its 50-day average volume of 656,100 shares. And to end, AKYA’s 100-day average volume is 463,633 shares with 100% of the long-term indicators pointing towards Sell for the stock.
